End-of-day quote
Taipei Exchange
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
17.2
TWD
|
+1.18%
|
|
+1.47%
|
-0.29%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,381
|
1,524
|
1,351
|
1,627
|
1,585
|
1,421
|
Enterprise Value (EV)
1 |
1,616
|
2,233
|
1,983
|
2,333
|
2,092
|
2,197
|
P/E ratio
|
13.1
x
|
13.4
x
|
23.1
x
|
23.8
x
|
6.09
x
|
2,234
x
|
Yield
|
5.85%
|
5.95%
|
4.88%
|
10.1%
|
6.23%
|
2.32%
|
Capitalization / Revenue
|
0.63
x
|
0.74
x
|
0.84
x
|
0.81
x
|
0.73
x
|
0.9
x
|
EV / Revenue
|
0.74
x
|
1.08
x
|
1.24
x
|
1.16
x
|
0.96
x
|
1.39
x
|
EV / EBITDA
|
7.01
x
|
9.74
x
|
13.2
x
|
13.6
x
|
13
x
|
71.5
x
|
EV / FCF
|
10.7
x
|
-2.45
x
|
3.01
x
|
-7.31
x
|
10.3
x
|
-11
x
|
FCF Yield
|
9.35%
|
-40.8%
|
33.3%
|
-13.7%
|
9.68%
|
-9.08%
|
Price to Book
|
1.15
x
|
1.23
x
|
1.12
x
|
1.34
x
|
1.2
x
|
1.16
x
|
Nbr of stocks (in thousands)
|
82,361
|
82,361
|
82,361
|
82,361
|
82,361
|
82,361
|
Reference price
2 |
16.76
|
18.50
|
16.40
|
19.75
|
19.25
|
17.25
|
Announcement Date
|
01/04/19
|
30/03/20
|
30/03/21
|
23/03/22
|
17/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,177
|
2,073
|
1,605
|
2,013
|
2,187
|
1,581
|
EBITDA
1 |
230.6
|
229.3
|
150.4
|
171.9
|
161.2
|
30.75
|
EBIT
1 |
122.7
|
128.5
|
57.64
|
84.56
|
81
|
-57.32
|
Operating Margin
|
5.63%
|
6.2%
|
3.59%
|
4.2%
|
3.7%
|
-3.63%
|
Earnings before Tax (EBT)
1 |
124.5
|
139.6
|
64.64
|
91.01
|
272.2
|
-34.79
|
Net income
1 |
106.2
|
114.8
|
58.41
|
68.65
|
263.7
|
0.636
|
Net margin
|
4.88%
|
5.54%
|
3.64%
|
3.41%
|
12.06%
|
0.04%
|
EPS
2 |
1.284
|
1.380
|
0.7092
|
0.8300
|
3.160
|
0.007722
|
Free Cash Flow
1 |
151.1
|
-910.1
|
659.8
|
-319.4
|
202.6
|
-199.4
|
FCF margin
|
6.94%
|
-43.9%
|
41.1%
|
-15.86%
|
9.26%
|
-12.62%
|
FCF Conversion (EBITDA)
|
65.54%
|
-
|
438.6%
|
-
|
125.69%
|
-
|
FCF Conversion (Net income)
|
142.3%
|
-
|
1,129.58%
|
-
|
76.81%
|
-
|
Dividend per Share
2 |
0.9804
|
1.100
|
0.8000
|
2.000
|
1.200
|
0.4000
|
Announcement Date
|
01/04/19
|
30/03/20
|
30/03/21
|
23/03/22
|
17/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
235
|
709
|
633
|
707
|
507
|
776
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.021
x
|
3.094
x
|
4.206
x
|
4.111
x
|
3.144
x
|
25.25
x
|
Free Cash Flow
1 |
151
|
-910
|
660
|
-319
|
203
|
-199
|
ROE (net income / shareholders' equity)
|
8.22%
|
8.76%
|
4.62%
|
6.01%
|
19.4%
|
-1.47%
|
ROA (Net income/ Total Assets)
|
3.76%
|
3.6%
|
1.5%
|
2.15%
|
2.01%
|
-1.44%
|
Assets
1 |
2,825
|
3,194
|
3,899
|
3,189
|
13,138
|
-44.14
|
Book Value Per Share
2 |
14.60
|
15.00
|
14.60
|
14.70
|
16.10
|
14.80
|
Cash Flow per Share
2 |
1.330
|
1.170
|
1.550
|
1.290
|
1.630
|
1.470
|
Capex
1 |
130
|
570
|
56.8
|
89.8
|
238
|
249
|
Capex / Sales
|
5.98%
|
27.49%
|
3.54%
|
4.46%
|
10.91%
|
15.76%
|
Announcement Date
|
01/04/19
|
30/03/20
|
30/03/21
|
23/03/22
|
17/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.29% | 43.19M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 43.02B | | +17.44% | 39.28B | | +6.62% | 33.09B | | +13.00% | 20.23B | | +15.64% | 17.39B | | +22.55% | 15.45B | | +7.34% | 15.07B |
Other Commodity Chemicals
|